The Russian Society of Cardiology (RSC) is an all-Russian non-commercial association bringing together experts in cardiology and related disciplines. Currently, there are 4500 physician members of the RSC. Among the RSC members are internists, cardiovascular surgeons, endocrinologists, and other specialists interested in cardiovascular diseases. The RSC is developing interdisciplinary approaches and cooperation with related medical specialties. It supports and develops professional communication with the Russian Atherosclerosis Society, the Society of Cardiovascular Prevention and Rehabilitation, Arterial Hypertension Society, and others. Since 2011, the President of the Russian Society of Cardiology has been Prof. Evgeny Shlyakhto, FESC, FACC, who is also a Member of the Russian Academy of Science and Director of The Federal Almazov Medical Research Centre, St Petersburg.

Reseapro, has launched its new business vertical Reseapropharma to serve global/ Indian pharmaceutical industry. Reseapro’s entry to Pharma industry is based out of decade old expertise and experience in serving the scientific research community for international journal publication through Manuscriptedit. At Reseapropharma we are providing clinical regulatory writing, pharmacovigilance and regulatory support to pharma and allied life science majors.